Jump to content

Moroxydine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 174.127.240.207 (talk) at 09:20, 25 December 2020 (Remove unrelated info). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Moroxydine
Names
IUPAC name
N-(Diaminomethylidene)morpholine-4-carboximidamide
Other names
Moroxidine
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.020.994 Edit this at Wikidata
EC Number
  • 223-093-1
KEGG
UNII
  • InChI=1S/C6H13N5O/c7-5(8)10-6(9)11-1-3-12-4-2-11/h1-4H2,(H5,7,8,9,10) ☒N
    Key: KJHOZAZQWVKILO-UHFFFAOYSA-N ☒N
  • InChI=1/C6H13N5O/c7-5(8)10-6(9)11-1-3-12-4-2-11/h1-4H2,(H5,7,8,9,10)
    Key: KJHOZAZQWVKILO-UHFFFAOYAH
  • C1COCCN1C(=N)N=C(N)N
Properties
C6H13N5O
Molar mass 171.20 g/mol
Pharmacology
J05AX01 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Moroxydine is an antiviral drug that was originally developed in the 1950s as an influenza treatment. It has potential applications against a number of RNA and DNA viruses.[1] Structurally moroxydine is a heterocyclic biguanidine.

References

  1. ^ Sheppard, S. (1994). "Moroxydine: The story of a mislaid antiviral". Acta dermato-venereologica. Supplementum. 183: 1–9. PMID 9868507.